Today: 4 June 2026
Browse Category

Artificial Intelligence 10 March 2026 - 12 March 2026

Oracle Stock Price Jumps After AI Cloud Forecast Eases Debt Fears

Oracle Stock Price Jumps After AI Cloud Forecast Eases Debt Fears

Oracle shares jumped 9.18% to $163.12 after the company raised its fiscal 2027 revenue target to $90 billion and reported a 325% surge in remaining performance obligations to $553 billion. Quarterly cloud revenue rose 44% to $8.9 billion. Oracle said many new AI contracts are backed by customer prepayments or client-supplied GPUs. Financing concerns remain despite $30 billion already raised toward a $50 billion target.
What to Know About AI Stocks Before the US Market Open Today: Oracle Revives the Trade, Adobe Up Next

What to Know About AI Stocks Before the US Market Open Today: Oracle Revives the Trade, Adobe Up Next

Oracle reported a 325% jump in contracted future revenue to $553 billion and raised its 2027 revenue target to $90 billion, driving AI stocks higher premarket despite oil prices weighing on futures. Nvidia announced a $2 billion investment in Nebius, while Meta unveiled four in-house AI chips. Amazon is seeking $37 billion in bonds to fund AI infrastructure. Atlassian will cut 1,600 jobs to shift focus to AI.
Palantir Stock Price Today: PLTR Holds Steady as Anthropic Lawsuit Tests Pentagon AI Work

Palantir Stock Price Today: PLTR Holds Steady as Anthropic Lawsuit Tests Pentagon AI Work

Palantir shares edged down 0.06% to $151.05 Wednesday as legal experts said Anthropic has a strong case against its Pentagon blacklisting, according to Reuters. Palantir’s Maven software, used in U.S. defense contracts, relies on Anthropic’s Claude AI. If the ban holds, Palantir may need to replace Claude in systems tied to over $1 billion in contracts. Anthropic sued the U.S. government Monday over the ban.
UiPath Stock Rises Ahead of Earnings as AI Pivot Faces Key Test

UiPath Stock Rises Ahead of Earnings as AI Pivot Faces Key Test

UiPath shares rose 2.8% to $11.91 Wednesday morning ahead of its quarterly results, still far below December’s $19.84 high. Wall Street expects about 26 cents a share on $465 million in revenue for the fourth quarter. UiPath recently secured AIUC-1 certification and acquired WorkFusion to expand in financial compliance. Investors remain cautious as the company competes with larger rivals like Microsoft.
Plug Power stock price rises as hydrogen firm eyes AI data-center power deals

Plug Power stock price rises as hydrogen firm eyes AI data-center power deals

Plug Power shares rose 2.1% to $2.17 Wednesday after reports the company may sell up to 250 megawatts of power into PJM Interconnection. Chairman Andy Marsh said Plug is seeking long-term contracts and is in talks with data-center and utility customers. Plug recently signed a $132.5 million deal with Stream Data Centers, aiming to unlock over $275 million from asset sales and cash releases.
UiPath secures AIUC-1 AI-agent safety certification ahead of earnings as investors await proof

UiPath secures AIUC-1 AI-agent safety certification ahead of earnings as investors await proof

UiPath said it received AIUC-1 certification for its AI agents, becoming the first enterprise automation platform to meet the new standard. Shares fell about 3% late Tuesday ahead of quarterly results due Wednesday. The certification comes as vendors emphasize security and control in AI tools. UiPath previously guided for fourth-quarter revenue of $462 million to $467 million.
Plug Power Eyes 250 MW PJM Power Bid in New AI Data Center Push

Plug Power Eyes 250 MW PJM Power Bid in New AI Data Center Push

Plug Power is seeking to sell up to 250 megawatts of power into PJM Interconnection, targeting data center operators and utilities with contracts of at least seven years, Chairman Andy Marsh told Bloomberg. Plug shares fell 3.2% to $2.12 in late trading. The company reported 2025 revenue up 12.9% to $710 million and ended the year with $368.5 million in unrestricted cash. Jose Luis Crespo became CEO on March 2.
Intel Corporation launches Core Series 2 edge AI chips as turnaround pressure builds

Intel Corporation launches Core Series 2 edge AI chips as turnaround pressure builds

Intel launched its Core Series 2 processors for industrial systems and previewed a Health & Life Sciences Edge AI suite at Embedded World in Nuremberg on Monday. The new chips target factories, robotics, and patient monitoring, and are designed for predictable response times with up to 12 performance cores. Intel shares rose 2.6% to $46.78 Tuesday. CEO Lip-Bu Tan continues to restructure the company amid supply constraints and leadership changes.
Amazon bond sale could hit $42 billion as AI spending race intensifies

Amazon bond sale could hit $42 billion as AI spending race intensifies

Amazon is seeking $37 billion to $42 billion in a bond sale across dollars and euros, with U.S. orders reaching $126 billion, Bloomberg reported. The dollar portion was increased to $37 billion, with a 10 billion euro sale expected Wednesday, according to the Financial Times. Amazon plans $200 billion in capital expenditures this year, up from $131 billion in 2025. The company last raised $15 billion in November.
CrowdStrike Stock Gets Morgan Stanley Upgrade as Strong Outlook Blunts AI Fears

CrowdStrike Stock Gets Morgan Stanley Upgrade as Strong Outlook Blunts AI Fears

CrowdStrike shares held steady at $434.25 Tuesday after Morgan Stanley upgraded the stock and raised its price target to $510. The company forecast fiscal 2027 revenue above Wall Street estimates and reported fourth-quarter revenue up 23% to $1.31 billion. Costs tied to the July 2024 Windows outage rose to $117.7 million for fiscal 2026 but narrowed last quarter. CrowdStrike recently agreed to acquire SGNL and Seraphic Security.
Corning Incorporated shares jump as AI fiber trade rebounds ahead of OFC 2026

Corning Incorporated shares jump as AI fiber trade rebounds ahead of OFC 2026

Corning shares climbed 6.5% to $137.50 midday Tuesday, with Ciena and Lumentum also up over 6%. The gains followed strong optical-fiber demand and a $6 billion Meta Platforms supply deal. Corning’s fourth-quarter optical communications sales rose 24% to $1.70 billion. Investors remain cautious ahead of the OFC 2026 conference next week in Los Angeles.
Cisco Systems folds Splunk into Nexus One to speed AI data center troubleshooting

Cisco Systems folds Splunk into Nexus One to speed AI data center troubleshooting

Cisco has integrated Splunk analytics into its Nexus Dashboard, enabling real-time network fault detection and automation for Nexus 9000 and Cisco 8000 switches and routers. The feature keeps sensitive telemetry data on premises, targeting compliance-focused customers. Cisco shares rose 3.4% Tuesday morning after the announcement. The move comes as Cisco faces competition from Arista and others in AI-driven networking.
Coherent Corp Stock Jumps Again as S&P 500 Entry Extends Nvidia-Backed AI Optics Rally

Coherent Corp Stock Jumps Again as S&P 500 Entry Extends Nvidia-Backed AI Optics Rally

Coherent Corp shares climbed nearly 6% Tuesday after the company said it will join the S&P 500 on March 23, following Nvidia’s $2 billion investment. The stock traded at $267.79 by late morning in New York. Coherent also launched new 980-nanometer micro-pump lasers ahead of the OFC telecom conference. Fiscal Q2 revenue rose 17% to $1.69 billion, with third-quarter guidance set at $1.70–$1.84 billion.
Goldman Sachs Pitches Hedge Funds New Swap Trade to Bet Against Software Loans Amid AI Fears

Goldman Sachs Pitches Hedge Funds New Swap Trade to Bet Against Software Loans Amid AI Fears

Goldman Sachs is offering hedge funds a total return swap to bet on corporate loans tied to software, as AI concerns spread in credit markets, Reuters reports. No trades have been executed yet. Morgan Stanley estimates software makes up 16% of the $1.5 trillion U.S. loan market, with half rated B- or lower. Private credit activity is rising, with major banks allocating tens of billions to the sector.
Applied Materials, Micron strike AI memory deal as $5 billion EPIC Center nears opening

Applied Materials, Micron strike AI memory deal as $5 billion EPIC Center nears opening

Applied Materials will partner with Micron Technology to develop advanced memory for AI systems at its $5 billion EPIC research center in Silicon Valley. Applied shares rose 1.9% and Micron gained 4.3% after the announcement. The companies will focus on DRAM, high-bandwidth memory, and NAND flash, with work spanning California and Idaho. Applied recently settled U.S. export allegations for $252 million.
Lam Research Corporation Joins IBM in Sub-1nm Chip Push as AI Demand Raises the Stakes

Lam Research Corporation Joins IBM in Sub-1nm Chip Push as AI Demand Raises the Stakes

Lam Research and IBM announced a five-year partnership to develop sub-1nm chipmaking processes, aiming to advance beyond current 2nm technology. Lam shares rose $4.49 to $215.64 after the news. The companies will use IBM’s Albany NanoTech Complex and Lam’s fabrication tools. ASML’s new High-NA EUV lithography systems, priced at about $400 million each, are expected to take years to fully integrate into production.
Intel launches edge AI chips as Lip-Bu Tan races to prove turnaround

Intel launches edge AI chips as Lip-Bu Tan races to prove turnaround

Intel launched new Core Series 2 processors for industrial and medical devices at Embedded World in Nuremberg, with systems available now and a healthcare software suite set for broader release in Q2. The company claims the chips outperform AMD's Ryzen 7 9700X on latency in its own tests. Intel shares rose 1.6% Tuesday morning in U.S. trading. Board chair Frank Yeary will retire in May, to be replaced by Craig Barratt.
1 41 42 43 44 45 203

Stock Market Today

  • LanzaTech JV Raises $75 Million in Hong Kong IPO, Shares Surge
    June 4, 2026, 2:26 PM EDT. LanzaTech Global's joint venture Beijing Shougang LanzaTech raised about $75 million through an initial public offering on the Hong Kong Stock Exchange. The company sold 40 million H-shares at roughly $1.86 per share, valuing the venture near $750 million. LanzaTech's stake adjusted to 8.38% post-IPO. The venture operates four commercial plants using LanzaTech's carbon recycling technology, reporting revenue between $77 million and $87 million from 2023 to 2025. Nasdaq-listed LanzaTech shares jumped over 26% to $6.90 following the listing, reflecting strong investor interest in sustainable fuel solutions.

Latest articles

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

4 June 2026
Grab Holdings’ U.S. shares jumped 2.9% to $3.51 as investors weighed strong Q1 results—revenue up 24% to $955 million, adjusted EBITDA up 46% to $154 million—and the consolidation of Indonesia’s Superbank, now majority-owned by Grab, against risks from higher fuel costs and regional regulation, leaving the stock sensitive to further updates on profitability and fintech growth.
Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs Jumps as Dow Sets New High

4 June 2026
Goldman Sachs shares surged 4.6% to $1,095.89, powering the Dow to an all-time high as investors rotated into financials; the move was amplified by Goldman’s high share price in the price-weighted Dow, while the bank’s lead role in the $75 billion SpaceX IPO and strong Q1 earnings added momentum, even as analysts flagged risks from high IPO valuations and geopolitical uncertainty.
Celsius Drops in New York After Texas Inquiry Hits Alani Nu Play

Celsius Drops in New York After Texas Inquiry Hits Alani Nu Play

4 June 2026
Celsius shares plunged 6.8% to near a 52-week low after Texas opened a probe into whether its Alani Nu drinks misled consumers about safety for minors, raising fresh legal and consumer-safety concerns just as the company relies on Alani Nu for growth and integration with PepsiCo’s distribution system.
Veru shares jump after Novo Nordisk deal draws traders

Veru shares jump after Novo Nordisk deal draws traders

4 June 2026
Veru shares soared 112% to $4.78 after announcing Novo Nordisk will supply Wegovy at no charge for Veru’s Phase 2b obesity trial, with Veru retaining global rights to enobosarm but granting Novo a right of first negotiation; analysts called the deal a “significant event” and kept $24–$25 targets, while Veru warned trial risks and reimbursement challenges remain.
CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics Jumps 12% in New York Trading

4 June 2026
CRISPR Therapeutics shares soared 11.7% to $58.15 after presenting at the Jefferies Global Healthcare Conference, with sector momentum lifting gene-editing stocks and the SPDR S&P Biotech ETF up 3.0%. Casgevy, its key sickle cell therapy, posted $43 million Q1 revenue, but a $122.9 million net loss and biotech risks mean the rally hinges on investor appetite and upcoming clinical updates.
Go toTop